Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 4, 2026
Reporting period
Not applicable
Filed with the SEC
May 6, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000105770-26-000060
Filed / recorded
May 6, 2026, 9:26 PM UTC
Added to OQRO
Oct 2, 2026, 12:29 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
WEST PHARMACEUTICAL SERVICES INC
Issuer CIK
105770
Ticker
WST
Reporting person
Janet Brutschea Haugen
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
May 4, 2026
Transaction code
A
Shares / units
791
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
2,372.752
Ownership form
Direct
Amendment
No
Footnotes from the filing
These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.